• The collaboration will provide laboratory equipment, technical support and engagement opportunities for BioLabs resident companies
• Builds on existing partnerships at BioLabs sites across the US, Germany and France

Hamburg, Germany and MUNICH, Germany – Eppendorf, a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world, and BioLabs, a global innovation infrastructure company creating the physical and community backbone that powers life science discovery worldwide, today announced the expansion of their collaboration to BioLabs’ new Munich site, BioLabs | TUM, extending a relationship that already includes BioLabs locations in the U.S, France and Germany. The partnership will provide biotech and life-science entrepreneurs with access to laboratory equipment, technical expertise and a connected innovation community.

Under the partnership, Eppendorf will participate as a Gold Sponsor of BioLabs | TUM in Munich. The collaboration reflects a shared commitment to strengthening the life-science ecosystem: BioLabs provides the space, community and operational environment in which startups can develop, while Eppendorf contributes laboratory technologies and expertise that support day-to-day research and growth, including providing instrumentation and related software, staff training programmes, and equipment maintenance, as well as delivering lectures and conferences. The site will provide opportunities for workshops, office hours, on-site events and other engagement activities for BioLabs’ resident companies.

Located within Munich’s dynamic innovation ecosystem, BioLabs | TUM began welcoming residents earlier this summer. The site provides shared and private laboratory spaces, offices, operational support and access to a community of entrepreneurs, mentors, investors and industry partners. It is designed to support the continued growth of the region’s life-science ecosystem in connection with the broader TUM Venture Labs.

“Expanding our collaboration with BioLabs to the new Munich site allows us to bring Eppendorf’s equipment and expertise closer to a new generation of biotech companies,” said Axel Ziemke, Vice President Central Area EMEA, Eppendorf Vertrieb Deutschland GmbH. “The partnership combines practical support for laboratories with opportunities for direct exchange between Eppendorf and the companies shaping the future of life science.”

“BioLabs’ partnership with Eppendorf spans more than a decade, and we are very proud to extend this long-standing collaboration to Munich,” said Johannes Fruehauf, CEO and Founder of BioLabs. “Our mission is to support entrepreneurs and innovative scientists as they bring breakthrough ideas to life, and we are confident that Eppendorf shares that commitment. We are excited to have Eppendorf join us in supporting the next generation of life-science companies in Munich and look forward to building on our collaboration in this important ecosystem.”

About the Eppendorf Group

Eppendorf is a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world.

The product portfolio of the business units Liquid Handling & Consumables, Separation & Instrumentation and Bioprocess includes, for example, pipettes, pipette tips, centrifuges, mixers, ultra-freezers and bioreactors for cell and gene research. In addition, Eppendorf offers a wide range of high-quality consumables. In fiscal year 2025, the Eppendorf Group recorded consolidated revenue of €924.0 million and invested €60.9 million in research and development (R&D).

Eppendorf products are used in academic or industrial research laboratories, such as pharmaceutical, biotech, chemical, and food industries, as well as clinical, environmental, forensic, and industrial laboratories for process analysis, production, and quality assurance.

Since 1945, the Eppendorf Group has been headquartered in Hamburg, Germany, and today operates production and R&D sites in Europe, Asia and North America and has subsidiaries in 30 countries. Today, the Group employs more than 4,000 people worldwide. They all act in accordance with the purpose of the company’s founders: to improve human living conditions.

About BioLabs

BioLabs is a global innovation infrastructure company creating the physical and community backbone that powers life science discovery worldwide. Through a growing network of premium shared laboratories and coworking spaces, BioLabs provides turnkey access to state-of-the-art research facilities, entrepreneurial programming, and deep industry and capital connections. These integrated ecosystems enable innovators – from early-stage founders to established R&D teams – to rapidly translate ideas into impact without the constraints of traditional lab ownership. The BioLabs network now spans major innovation hubs across the United States, Canada, Europe, and Asia, serving as a catalyst for collaboration and a launchpad for breakthroughs that advance human health and sustainability.